Se connecter Inscription gratuite

Apellis Pharmaceuticals Inc Revenu

Quel est le Revenu de Apellis Pharmaceuticals Inc?

Le Revenu de Apellis Pharmaceuticals Inc est -$332.89

Quelle est la définition de Revenu?

Le résultat net disponible pour les actionnaires ordinaires correspond au résultat net moins les dividendes privilégiés versés.

Net income available to common shareholders are the profits remaining after the company pays all of its suppliers, employees, service providers, creditors, and preferred shareholders. In other words, this is revenue less all expenses and preferred dividends. The number measures common shareholders' claim on the company's cash flows.

Revenu des entreprises dans Health Care secteur sur NASDAQ par rapport à Apellis Pharmaceuticals Inc

Que fait Apellis Pharmaceuticals Inc?

apellis pharmaceuticals is an early stage biotechnology company applying immunotherapy to auto-immune diseases, with an initial emphasis on diseases of the lungs such as asthma and chronic obstructive pulmonary disease (copd), diseases of the retina such as age-related macular degeneration (amd), and rare hematological diseases such as paroxysmal nocturnal hemoglobinuria (pnh). apellis believes that targeting a key element in the immune system called the complement system can have profound disease modifying benefits. we call this approach complement immunotherapy.

Entreprises avec revenu similaire à Apellis Pharmaceuticals Inc